Amarin Corp Plc (AMRN)

[ziploc_1]

L..."Is there any data on script volume for Amrn reps versus Kowa reps?"

The relationship between Kowa and Amarin is scheduled to end in 2018. The data on script volume may have a role determining whether it would be useful for Amarin and Kowa to continue the relationship This would be a worthwhile topic for discussion at the next C.C. I imagine that Kowa reps have been successful in detailing Kowa's Lovastatin and I hope they have been equally successful in detailing Amarin's Vascepa.